SCHEMBL19704320

SCHEMBL19704320

CN1CCC2(CC1)CC1CCOC1C2

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19704095 1.00 KMT2A (0.33) KMT2A
SCHEMBL20964348 0.81 GRIN2D (0.30)
SCHEMBL20964355 0.81 GRIN2D (0.30)
SCHEMBL23508652 0.76 TSHR (0.35)
SCHEMBL24080919 0.74
SCHEMBL23508658 0.72 HRH3 (0.33) KMT2A
SCHEMBL19704093 0.72 HTT (0.35)
SCHEMBL22796149 0.70 TSHR (0.34)
SCHEMBL13865337 0.68 CHRM2 (0.36)
SCHEMBL24881000 0.67 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4108659-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS Jacobio Pharmaceuticals Co., Ltd. (CN) 2022-12-28 EP disclosed
EP-3464272-B1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO LTD (CN) 2021-12-08 EP disclosed
WO-2017211303-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2017-12-14 WO disclosed